Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Greenbrook TMS Inc. (GBNH : NSDQ)
 
 • Company Description   
Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, principally in the United States. Greenbrook TMS Inc. is based in TORONTO.

Number of Employees: 430

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.31 Daily Weekly Monthly
20 Day Moving Average: 21,605 shares
Shares Outstanding: 17.80 (millions)
Market Capitalization: $23.37 (millions)
Beta: 2.57
52 Week High: $13.01
52 Week Low: $1.27
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -40.34% -35.92%
12 Week -52.27% -44.00%
Year To Date -68.90% -61.25%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
890 YONGE STREET 7TH FLOOR
-
TORONTO,A6 M4W 3P4
CAN
ph: 416-322-9700
fax: -
investorrelations@greenbrooktms.com http://www.greenbrooktms.com
 
 • General Corporate Information   
Officers
Bill Leonard - President and Chief Executive Officer
Erns Loubser - Chief Financial Officer and Treasurer
Diana Shi - Senior Vice President
Brian P. Burke - Director
Colleen Campbell - Director

Peer Information
Greenbrook TMS Inc. (CMTI)
Greenbrook TMS Inc. (CMWLQ)
Greenbrook TMS Inc. (AHG.)
Greenbrook TMS Inc. (ROIX)
Greenbrook TMS Inc. (M.DCE)
Greenbrook TMS Inc. (DHSM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-OUTP/HM CRE
Sector: Medical
CUSIP: 393704309
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 17.80
Most Recent Split Date: (:1)
Beta: 2.57
Market Capitalization: $23.37 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.18 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.26 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.65
Price/Cash Flow: -
Price / Sales: 0.43
EPS Growth
vs. Year Ago Period: 21.43%
vs. Previous Quarter: -29.41%
Sales Growth
vs. Year Ago Period: 15.49%
vs. Previous Quarter: -7.00%
ROE
06/30/22 - -
03/31/22 - -157.80
12/31/21 - -189.28
ROA
06/30/22 - -
03/31/22 - -34.90
12/31/21 - -35.88
Current Ratio
06/30/22 - -
03/31/22 - 0.95
12/31/21 - 1.34
Quick Ratio
06/30/22 - -
03/31/22 - 0.95
12/31/21 - 1.34
Operating Margin
06/30/22 - -
03/31/22 - -46.27
12/31/21 - -47.42
Net Margin
06/30/22 - -
03/31/22 - -46.27
12/31/21 - -47.42
Pre-Tax Margin
06/30/22 - -
03/31/22 - -46.39
12/31/21 - -47.63
Book Value
06/30/22 - -
03/31/22 - 0.50
12/31/21 - 0.93
Inventory Turnover
06/30/22 - -
03/31/22 - -
12/31/21 - -
Debt-to-Equity
06/30/22 - -
03/31/22 - 4.31
12/31/21 - 2.26
Debt-to-Capital
06/30/22 - -
03/31/22 - 81.17
12/31/21 - 69.35
 

Powered by Zacks Investment Research ©